DNMR — Danimer Scientific Cashflow Statement
0.000.00%
Last trade - 00:00
- $116.32m
- $418.80m
- $53.22m
- 14
- 62
- 36
- 30
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -0.004 | -8.85 | -60.1 | -180 |
Depreciation | ||||
Deferred Taxes | ||||
Non-Cash Items | — | -2.37 | 27.6 | 118 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 0.004 | -7.18 | -28.9 | -19.3 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Change in Other Liabilities | ||||
Cash from Operating Activities | 0 | -13.8 | -63 | -61.8 |
Capital Expenditures | — | -38.3 | -185 | -164 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | — | 0.009 | -151 | -18 |
Acquisition of Business | ||||
Sale of Fixed Assets | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | — | -38.3 | -336 | -182 |
Financing Cash Flow Items | -0.005 | 382 | -12 | -1.37 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 0.02 | 423 | 306 | 21.8 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0.02 | 371 | -92.9 | -223 |